We proudly like to announce, that we opened our first German subsidiary on the first of April 2020 in the western part of Germany. The new office is located in Siegburg (between Cologne and Bonn), which has an ideally infrastructure for travelling (ICE railway station nearby). Our Managing Director Petra Löhmer, has more than 25 years of clinical research experience. The new subsidiary enables small to midsize biotech and medical device companies of the western and southern part of Germany to have a closer contact to our clinical research experts. Petra is happy to discuss your potential new projects and collaboration interests.

General
High-Risk AI Requirements for AI-Based Medical Devices: What the EU AI Act Adds to MDR Compliance
Artificial intelligence is becoming increasingly important in medical technology. From diagnostic support tools to software that interprets clinical data, AI-based medical devices promise faster workflows,
